{
    "code": "02021173",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021173",
    "time": "2023-04-07 03:29:48",
    "許可證字號": "衛署藥輸字第021173號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/09\/26",
    "發證日期": "92\/12\/05",
    "許可證種類": "製　劑",
    "舊證字號": "02017107",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202117302",
    "中文品名": "新明發健注射液",
    "英文品名": "STRONGER NEO MINOPHAGEN C INJECTION",
    "適應症": "維護肝臟正常功能、藥物過敏症、食物過敏",
    "劑型": "270注射劑",
    "包裝": "20毫升安瓿 100安瓿以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL), CYSTEINE (HCL L-), GLYCYRRHIZINATE MONOAMMONIUM (MGR)",
    "限制項目": "02輸　入",
    "申請商名稱": "0407901100  衛采製藥股份有限公司",
    "申請商地址": "台北市長安東路一段十八號九樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0608000  MINOPHAGEN PHARMACEUTICAL CO., LTD. ZAMA FACTORY.",
            "製造廠廠址": "2-2-3, KOMATSUBARA, ZAMA-SHI, KANAGAWA, JAPAN",
            "製造廠公司地址": "3-2-11, NISHI-SHINJUKU, SHINJUKU-KU, TOKYO, JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4020102400",
            "成分名稱": "GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL)",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4020109512",
            "成分名稱": "CYSTEINE (HCL L-)",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200004650",
            "成分名稱": "GLYCYRRHIZINATE MONOAMMONIUM (MGR)",
            "含量描述": "",
            "含量": "2.6500000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "無色、透明之注射液",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "SNMC ampoule-106-06-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021173&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "SMC_TW-H-004_20180524-107-06-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021173&Seq=004&Type=9"
        },
        {
            "title": "020211730001___20121109.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021173&Seq=002&Type=9"
        },
        {
            "title": "SNMC carton (TW-3)_新增條碼-108-10-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021173&Seq=009&Type=8"
        },
        {
            "title": "SNMC_packaging+materials-106-06-20-107-06-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021173&Seq=008&Type=8"
        }
    ]
}